Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
基本信息
- 批准号:10224352
- 负责人:
- 金额:$ 37.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntibodiesAntigen-Presenting CellsAntigensAreaAstrocytesAutoimmunityAutomobile DrivingBiologicalBrainCD44 AntigensCNS autoimmunityCellsCentral Nervous System DiseasesCervical lymph node groupCharacteristicsClinicalDataDendritic CellsDevelopmentDiseaseDrainage procedureDura MaterEndothelial CellsExperimental Autoimmune EncephalomyelitisFlow CytometryFluid BalanceFunctional disorderGene Expression ProfileGlial Fibrillary Acidic ProteinHeterogeneityITGAX geneImmuneImmunohistochemistryIn SituInflammatoryLigandsLiquid substanceLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphedemaLymphoidLymphoid CellMediatingMultiple SclerosisMusMyeloid Progenitor CellsNeuronsOligodendrogliaPathogenesisPathogenicityPathologicPathologyPathway interactionsPeripheralPharmacologyProteinsReceptor Protein-Tyrosine KinasesRegulationRegulatory PathwayReporterRoleSculptureSourceSpinal CordStrokeT-LymphocyteTestingTherapeuticTimeTissuesTransgenic MiceTransgenic OrganismsTraumaTyrosine Kinase InhibitorVEGFC geneVascular Endothelial Growth Factor Receptor-3Workadaptive immunitycribriform platedraining lymph nodein vivo imaginginflammatory milieulymph nodeslymphatic vesselmacrophagemonocytemouse modelnestin proteinneuroinflammationpodoplaninrecruittargeted treatmenttesting accesstranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Adaptive immunity in most tissues of the body involves the drainage of antigens or antigen presenting cells within
conventional lymphatic vessels to the draining lymph nodes where antigen is presented to T cells. However,
there are no conventional lymphatic vessels within the CNS parenchyma. Alternatively, it has been hypothesized
that antigens, antigen presenting cells, and CSF may drain from the CNS into lymphatics near the cribriform
plate or dura to maintain fluid homeostasis and antigen drainage during steady-state conditions, yet little is known
about the role of these lymphatic vessels during neuroinflammation.
We discovered that lymphatic vessels near the cribriform plate undergo extensive in situ neo-lymphangiogenesis
during experimental autoimmune encephalomyelitis (EAE), a mouse model of Multiple Sclerosis. Our preliminary
data show that these neo-lymphatic vessels near the cribriform plate are functionally able to drain both CSF and
cells that were once in the CNS parenchyma. We further found the during EAE, VEGFC protein is produced by
infiltrating macrophages and dendritic cells to promote VEGFR3 dependent neo-lymphangiogenesis near the
cribriform plate. These data are the first to describe neo-lymphangiogenesis near the cribriform plate during
neuroinflammation. The long-term objective of this project is to characterize the functionality and contribution
of newly formed lymphoid vessels near to the cribriform plate to autoimmunity and stroke of the CNS.
The specific objectives of this proposal are (1) to define the characteristics and regulatory mechanisms driving
neo-lymphangiogenesis near the cribriform plate (Aim 1); (2) to test the functionality of neo-lymphatic vessels
near the cribriform plate and compare them to different CNS area lymphatics (Aim 2); and (3) to understand the
translational value of exacerbating or inhibiting neo-lymphangiogenesis near the cribriform plate in order to treat
CNS diseases (Aim 3).
Pharmacological inhibition or exacerbation of neo-lymphangiogensis to modulate pathology in CNS diseases
may have potential therapeutic values for CNS autoimmunity and ischemic trauma.
项目摘要/摘要
体内大多数组织中的获得性免疫包括排出体内的抗原或抗原提呈细胞
传统的淋巴管通向引流的淋巴结,抗原被提呈给T细胞。然而,
中枢神经系统实质内无常规淋巴管。或者,它是被假设的
这些抗原、抗原提呈细胞和脑脊液可能从中枢神经系统流入筛骨附近的淋巴管。
平板或硬脑膜在稳态条件下维持液体平衡和抗原排出,但知之甚少。
关于这些淋巴管在神经炎症中的作用。
我们发现筛板附近的淋巴管经历了广泛的原位新生淋巴管生成。
在实验性自身免疫性脑脊髓炎(EAE)期间,建立多发性硬化症的小鼠模型。我们的预赛
数据显示,筛板附近的这些新淋巴管在功能上能够排出脑脊液和脑脊液
曾经在中枢神经系统实质中的细胞。我们进一步发现,在EAE过程中,VEGFC蛋白是由
侵袭巨噬细胞和树突状细胞促进血管内皮生长因子受体3依赖的新淋巴管生成
筛板。这些数据首次描述了筛板附近的新生淋巴管生成。
神经炎。该项目的长期目标是确定功能和贡献的特征
筛板附近新形成的淋巴管与自身免疫和中枢神经系统卒中有关。
这项提案的具体目标是(1)界定驱动程序的特征和监管机制
筛板附近的新淋巴管生成(目标1);(2)测试新淋巴管的功能
并与不同的中枢神经系统区域的淋巴管进行比较(目标2);以及(3)了解
加重或抑制筛板附近新生淋巴管生成对治疗的意义
中枢神经系统疾病(目标3)。
药物抑制或加重新生淋巴管生成以调节中枢神经系统疾病的病理
可能对中枢神经系统自身免疫和缺血性损伤有潜在的治疗价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zsuzsanna Fabry其他文献
Zsuzsanna Fabry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zsuzsanna Fabry', 18)}}的其他基金
Regulation of Neuroinflammation by Meningeal Lymphatics
脑膜淋巴管对神经炎症的调节
- 批准号:
10581900 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Regulation of Neuroinflammation by Meningeal Lymphatics
脑膜淋巴管对神经炎症的调节
- 批准号:
10682552 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10187600 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10620761 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
人类疾病的细胞和分子发病机制研究生培训
- 批准号:
10413879 - 财政年份:2020
- 资助金额:
$ 37.61万 - 项目类别:
Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
- 批准号:
9769903 - 财政年份:2018
- 资助金额:
$ 37.61万 - 项目类别:
Neuroinflammation-induced lymphangiogenesis in the CNS
中枢神经系统中神经炎症诱导的淋巴管生成
- 批准号:
10449330 - 财政年份:2018
- 资助金额:
$ 37.61万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 37.61万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 37.61万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 37.61万 - 项目类别:














{{item.name}}会员




